Clinical Trial

Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease

Study acronym: PDCogniCare
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.
Trial Details
NCT Number NCT07114354
Lead Sponsor The University of Queensland
Collaborators: Medical Research Future Fund, Metro South Health, Metro North Health, Queensland University of Technology, University of Sydney, OPN365, Australian Dementia Network, Dementia Australia, Lions Club of Brisbane Inner North, Parkinson's Queensland
Conditions Dementia (Diagnosis), Parkinson Disease Dementia (PDD), Parkinson Disease (PD)
Enrollment 275 participants
Start Date 2025-08-18
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-11